88339KAA0THERAVANCE BIOPHARMA INC
CUSIP 88339KAA0 · debt
No tracked investor reported shares of THERAVANCE BIOPHARMA INC (88339KAA0) for Q3 2022. Seth Klarman sold out of its position this quarter.
Holders · Q3 2022
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding 88339KAA0 · Q3 2022
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Seth Klarman | 0.38% | 28,104,000 | $25.9M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2022 | 0 | 0 | 1 | $0 | — |
| Q2 2022 | 1 | 0 | 0 | $25.9M | $0.92 |
| Q1 2022 | 1 | 0 | 0 | $28.6M | $0.95 |
| Q4 2021 | 1 | 0 | 0 | $28.8M | $0.96 |
| Q3 2021 | 1 | 0 | 0 | $27.6M | $0.92 |
| Q2 2021 | 1 | 0 | 0 | $28.6M | $0.95 |
| Q1 2021 | 1 | 0 | 0 | $30.6M | $1.02 |
| Q4 2020 | 1 | 0 | 0 | $28.4M | $0.95 |
| Q3 2020 | 1 | 0 | 0 | $26.3M | $0.88 |
| Q2 2020 | 1 | 0 | 0 | $29.2M | $0.97 |
| Q1 2020 | 1 | 0 | 0 | $28.7M | $0.96 |
| Q4 2019 | 1 | 0 | 0 | $31.1M | $1.04 |
| Q3 2019 | 1 | 0 | 0 | $27.7M | $0.92 |
| Q2 2019 | 1 | 0 | 0 | $25.7M | $0.86 |
| Q1 2019 | 1 | 0 | 0 | $29.2M | $0.97 |
| Q4 2018 | 1 | 0 | 0 | $30.9M | $1.03 |
| Q3 2018 | 1 | 0 | 0 | $34.6M | $1.15 |
| Q2 2018 | 1 | 0 | 0 | $30M | $1.00 |
| Q1 2018 | 1 | 0 | 0 | $30.2M | $1.01 |
| Q4 2017 | 1 | 0 | 0 | $33M | $1.10 |
| Q3 2017 | 1 | 0 | 0 | $37.1M | $1.24 |
| Q2 2017 | 1 | 0 | 0 | $40.4M | $1.35 |
| Q1 2017 | 1 | 0 | 0 | $37.8M | $1.26 |
| Q4 2016 | 1 | 1 | 0 | $34.1M | $1.14 |